Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 552 | 20,752 | 2,044 | 2,145 | 1,287 |
| Operating Income | -552 | -20,752 | -2,044 | -2,145 | -1,287 |
| Interest Expense | 132 | 131 | 130 | 120 | 138 |
| Other Income | 6 | 226 | -37 | 7 | 0 |
| Pre-tax Income | -679 | -20,657 | -2,211 | -2,257 | -1,425 |
| Income Tax | N/A | -852 | N/A | N/A | -3 |
| Net Income Continuous | -679 | -19,806 | -2,211 | -2,257 | -1,422 |
| Net Income | $-679 | $-19,806 | $-2,211 | $-2,257 | $-1,422 |
| EPS Basic Total Ops | -0.43 | -2.56 | -0.46 | -0.73 | 1.79 |
| EPS Basic Continuous Ops | -0.44 | -2.56 | -0.46 | -0.73 | 1.79 |
| EPS Diluted Total Ops | -0.43 | -2.56 | -0.46 | -0.73 | 1.79 |
| EPS Diluted Continuous Ops | -0.44 | -2.56 | -0.46 | -0.73 | 1.79 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.15 | -0.46 | -0.73 | N/A |
| EBITDA(a) | $-552 | $-20,752 | $-2,044 | $-2,145 | $-1,287 |